These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31069281)

  • 1. An evaluation of irreversible electroporation thresholds in human prostate cancer and potential correlations to physiological measurements.
    Campelo S; Valerio M; Ahmed HU; Hu Y; Arena SL; Neal RE; Emberton M; Arena CB
    APL Bioeng; 2017 Dec; 1(1):016101. PubMed ID: 31069281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
    Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
    Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences.
    Scheltema MJ; O'Brien TJ; van den Bos W; de Bruin DM; Davalos RV; van den Geld CWM; Laguna MP; Neal RE; Varkarakis IM; Skolarikos A; Stricker PD; de Reijke TM; Arena CB; de la Rosette J
    Ther Adv Urol; 2019; 11():1756287219852305. PubMed ID: 31217820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models.
    Neal RE; Garcia PA; Kavnoudias H; Rosenfeldt F; Mclean CA; Earl V; Bergman J; Davalos RV; Thomson KR
    IEEE Trans Biomed Eng; 2015 Feb; 62(2):561-9. PubMed ID: 25265626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).
    Kos B; Voigt P; Miklavcic D; Moche M
    Radiol Oncol; 2015 Sep; 49(3):234-41. PubMed ID: 26401128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A statistical model for multidimensional irreversible electroporation cell death in tissue.
    Golberg A; Rubinsky B
    Biomed Eng Online; 2010 Feb; 9():13. PubMed ID: 20187951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Characterization of Parameters Affecting High-Frequency Irreversible Electroporation Lesions.
    Miklovic T; Latouche EL; DeWitt MR; Davalos RV; Sano MB
    Ann Biomed Eng; 2017 Nov; 45(11):2524-2534. PubMed ID: 28721494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis on reversible/irreversible electroporation region in lung adenocarcinoma cell model in vitro with electric pulses delivered by needle electrodes.
    Lv Y; Tang X; Peng W; Cheng X; Chen S; Yao C
    Phys Med Biol; 2020 Nov; 65(22):225001. PubMed ID: 33053520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive therapeutic planning for irreversible electroporation treatment of spontaneous malignant glioma.
    Garcia PA; Kos B; Rossmeisl JH; Pavliha D; Miklavčič D; Davalos RV
    Med Phys; 2017 Sep; 44(9):4968-4980. PubMed ID: 28594449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a statistical model for cervical cancer cell death with irreversible electroporation in vitro.
    Yang Y; Moser MAJ; Zhang E; Zhang W; Zhang B
    PLoS One; 2018; 13(4):e0195561. PubMed ID: 29694357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
    Davalos RV; Bhonsle S; Neal RE
    Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage.
    Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible electroporation: state of the art.
    Wagstaff PG; Buijs M; van den Bos W; de Bruin DM; Zondervan PJ; de la Rosette JJ; Laguna Pes MP
    Onco Targets Ther; 2016; 9():2437-46. PubMed ID: 27217767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of irreversible electroporation for the treatment of breast cancer and other heterogeneous systems.
    Neal RE; Davalos RV
    Ann Biomed Eng; 2009 Dec; 37(12):2615-25. PubMed ID: 19757056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation: a new ablation modality--clinical implications.
    Rubinsky B; Onik G; Mikus P
    Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomically Realistic Simulations of Liver Ablation by Irreversible Electroporation: Impact of Blood Vessels on Ablation Volumes and Undertreatment.
    Qasrawi R; Silve L; Burdío F; Abdeen Z; Ivorra A
    Technol Cancer Res Treat; 2017 Dec; 16(6):783-792. PubMed ID: 28093955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by "electric field sinks".
    Golberg A; Bruinsma BG; Uygun BE; Yarmush ML
    Sci Rep; 2015 Feb; 5():8485. PubMed ID: 25684630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation ablation: is all the damage nonthermal?
    Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
    Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical Characterization of Human Biological Tissue for Irreversible Electroporation Treatments.
    Beitel-White N; Bhonsle S; Martin RCG; Davalos RV
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():4170-4173. PubMed ID: 30441274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.